139481-41-7

• 常用中文名：1-((2'-氰基-[1,1'-联苯]-4-基)甲基)-2-乙氧基-1H-苯并[d]咪唑-7-羧酸乙酯
• 常用英文名：Ethyl-2-ethoxy-1-[[(2'-cyanobiphenyl-4-yl)methyl]benzimidazole]-7-carboxylate
• CAS号：139481-41-7
• 分子式：C₂₆H₂₃N₃O₃
• 分子量：425.479
• 发布时间：2018-09-02 19:33:27
• 更新时间：2026-07-09 07:56:09

名称

• 中文名: 2-乙氧基-1-[[(2'-腈基连苯-4-取代)甲基]苯并咪唑]-7-羧酸乙酯
• 英文名: Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
• 中文别名: 2-乙氧基-1-[[(2'-氰基联苯-4-取代)甲基]苯并咪唑]-7-羧酸乙酯; 阿齐沙坦中间体乙酯; 2-乙氧基-1-[[(2'-腈基连苯-4-取代)甲基]苯并咪唑]-7-羧酸乙酯 (乙酯C6; 坎地沙坦酯中间体C6乙酯; 坎地沙坦中间体乙酯C6; 坎地沙坦酯杂质C6; 坎地环合物; 2-乙氧基-1-[(2'-氰基苯基-4-基)-甲基]-1HBENZIMIDAZOLE-7-羧酸酯; 坎地沙坦酯中间体C6; 1-[(2'-氰基联苯-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸乙酯; 坎地沙坦中间体(乙酯C6); 坎地沙坦酯C6; 2-乙氧基-1-[ [(2'-腈基联苯-4-取代)甲基]苯并咪唑]-7-羧酸乙酯; 坎地沙坦酯中间体 C6; 1-((2'-氰基联苯-4-基)甲基)-2-乙氧基-1H-苯并[D]咪唑-7-羧酸乙酯; 坎地沙坦酯杂质47; 坎地沙坦酯中间体乙酯; 2-乙氧基2-乙氧基-1-[[(2'-腈基连苯-4-取代)甲基]苯并咪唑]-7-羧酸乙酯-1-[[(2'-腈基连苯-4-取代)甲基]苯并咪唑]-7-羧酸乙酯; 阿齐沙坦杂质37; 坎地沙坦酯中间体2; 2-乙氧基-1-[[(2’-腈基连苯-4-取代)甲基]苯并咪唑]-7-羧酸乙酯; 美阿沙坦钾杂质1; 2-乙氧基-1-[[(2'-腈基联苯-4-基)甲基]-1H-苯并咪唑]-7-羧酸乙酯; 2 - 乙氧基 - 1-[[(2'- 腈基连苯 - 4 - 取代) 甲基] 苯并咪唑]-7 - 羧酸乙酯(坎地沙坦酯中间体(乙酯 C6)); 1-((2'-氰基-[1,1'-联苯]-4-基)甲基)-2-乙氧基-1H-苯并[D]咪唑-7-羧酸乙酯; 坎地化合物(乙酯); 2-乙氧基-1-[(2'-氰基联苯-4-基)甲基]苯并咪唑-7-羧酸乙酯; 坎地沙坦酯中间体乙酯C6; 坎地沙坦酯杂质ZY1; 乙酯C6; 2-乙氧基-1-[[(2'-氰基联苯-4-取代)甲基]苯并咪唑]-7-羧酸乙酯,ETHYL-2-ETHOXY-1-[[(2'-CYANOBIPHENYL-4-YL)METHYL]BENZIMIDAZOLE]-7-CBOXYLATE 2-乙氧基-1-[[(22-乙氧基-1-[[(2 2-乙氧基-1-[[(2'-氰基联; 坎地沙坦酯杂质11; 坎地沙坦中间体(CANDESTANINTERMEDIATE),C6; 乙基-2-乙氧基-1-[[(2'-腈基联苯-4-取代)甲基]苯并咪唑]-7-羧酸; 1-[(2'-氰基联苯-4-基)]-2-乙氧基-苯并咪唑-7-羧酸乙酯
• 英文别名: Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimida; [4-(2-cyanophenyl)phenyl]Methyl 2-ethoxy-1-ethyl-1H-1,3-benzodiazole-7-cboxylate; ETHYL 3-[[4-(2-CYANOPHENYL)PHENYL]METHYL]-2-ETHOXYBENZIMIDAZOLE-4-CBOXYLATE; 1H-Benzimidazole-7-cboxylic acid,1-((2′-cyano(1,1′-biphenyl)-4-yl)methyl)-2-ethoxy-ethylester; 1H-Benzimidazole-7-cboxylicacid-1-[(2′cyano[1,1′- biphenyl]-4-yl)methyl]-2-ethoxy-ethylester; 1H-Benzimidazole-7-carboxylic acid, 1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-, ethyl ester; Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] BenziMidazole]-7-Cboxylate,C6; Ethyl 1-[(2'-Cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-cboxylate; C6 Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Cboxylate; Ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-cboxylate; Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl]Benzimidazole]-7-Cboxylate 139-7 Azilstan; Candestan Cilexetil Impurity 47; Ethyl 1-((2'-cyano-biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazol-7-cboxylate; 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-cboxylic acid ethyl ester (Intermediate of Azilstan); Ethyl-2-Ethoxy-1-[[(2-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Cboxylat; Azistan Impurity 18; Candestan cilexetil impurity C6; Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Cboxylate(C6 ethyleste); Ethyl 1-[(2'-cyano-4-biphenylyl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate; H-Benzimidazole-7-Cboxylicacid,1-[(2'-cyano[1.1'biphenyl]-4-yl)methyl]-2-ethoxy-ethylester; 1H-benzimidazole-7-carboxylicacid,1-[(2-cyano-[1,1’-biphenyl]-4-yl)methyl]-2-ethoxy-,ethyl ester; Ethyl-2-ethoxy-1-[[(2’ Ethyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate; 2-Ethoxy-1-[[(2'-cyanobiphenyl-4-yl)methyl]benzimidazole]-7-cboxylicacidethylester; Ethyl 1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-cboxylate; Azilstan Impurity 37; 1H-Benzimidazole-7-cboxylicacid,1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-ethylester; Ethyl 2-ethoxy-1-[(2'-cyanobiphenyl-4-yl)methyl]-1H-benzimidazole-7-cboxylate; ethyl 3-[[4-(2-cyanophenyl)phenyl]methyl]-2-ethoxybenzimidazole-4-carboxylate; cyanobiphenyl-4-yl)methyl]benzimidazole]-7-cboxylate; Azistan Impurity 33; Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-cboxylate; Ethyl-2-Ethoxy-1-[[(2'; Candestan Cilexetil Impurity ZY1; 3-[[4-(2-cyanophenyl)phenyl]methyl]-2-ethoxy-4-benzimidazolecboxylic acid ethyl ester; Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Cboxylate; CANDESTAN C; Ethyl 1-(2'-cyano-biphenyl-4-yl methyl)-2-ethoxy benzimidazole-7-cboxylate

物化性质

• 密度: 1.2±0.1 g/cm3
• 沸点: 637.5±65.0 °C at 760 mmHg
• 分子式: C₂₆H₂₃N₃O₃
• 分子量: 425.479
• 闪点: 339.4±34.3 °C
• 精确质量: 425.173950
• PSA: 77.14000
• LogP: 5.98
• 蒸汽压: 0.0±1.9 mmHg at 25°C
• 折射率: 1.612
• 储存条件: 室温，干燥

安全

• 危害码 (欧洲): Xi

上下游产品

上游产品  0
下游产品  4
863031-21-4 139481-58-6 147403-03-0 147403-52-9